TY - JOUR
T1 - The phosphoenolpyruvate
T2 - Sugar phosphotransferase system is involved in sensitivity to the glucosylated bacteriocin sublancin
AU - Garcia De Gonzalo, C. V.
AU - Denham, E. L.
AU - Mars, R. A.T.
AU - Stülke, J.
AU - Van Der Donk, W. A.
AU - Van Dijl, J. M.
N1 - Publisher Copyright:
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - The mode of action of a group of glycosylated antimicrobial peptides known as glycocins remains to be elucidated. In the current study of one glycocin, sublancin, we identified the phosphoenolpyruvate: sugar phosphotransferase system (PTS) of Bacillus species as a key player in bacterial sensitivity. Sublancin kills several Gram-positive bacteria, such as Bacillus species and Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA). Unlike other classes of bacteriocins for which the PTS is involved in their mechanism of action, we show that the addition of PTS-requiring sugars leads to increased resistance rather than increased sensitivity, suggesting that sublancin has a distinct mechanism of action. Collectively, our present mutagenesis and genomic studies demonstrate that the histidine-containing phosphocarrier protein (HPr) and domain A of enzyme II (PtsG) in particular are critical determinants for bacterial sensitivity to sublancin.
AB - The mode of action of a group of glycosylated antimicrobial peptides known as glycocins remains to be elucidated. In the current study of one glycocin, sublancin, we identified the phosphoenolpyruvate: sugar phosphotransferase system (PTS) of Bacillus species as a key player in bacterial sensitivity. Sublancin kills several Gram-positive bacteria, such as Bacillus species and Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA). Unlike other classes of bacteriocins for which the PTS is involved in their mechanism of action, we show that the addition of PTS-requiring sugars leads to increased resistance rather than increased sensitivity, suggesting that sublancin has a distinct mechanism of action. Collectively, our present mutagenesis and genomic studies demonstrate that the histidine-containing phosphocarrier protein (HPr) and domain A of enzyme II (PtsG) in particular are critical determinants for bacterial sensitivity to sublancin.
UR - http://www.scopus.com/inward/record.url?scp=84946216062&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946216062&partnerID=8YFLogxK
U2 - 10.1128/AAC.01519-15
DO - 10.1128/AAC.01519-15
M3 - Article
C2 - 26282429
AN - SCOPUS:84946216062
SN - 0066-4804
VL - 59
SP - 6844
EP - 6854
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 11
ER -